Molycorp (MCP) has its price target lowered again by JPMorgan, this time to $8.50 as the firm believes additional capital raises will be needed. It was JPM's Mike Gambardella who called out management on this month's earnings call for their inconsistency regarding funding issues and then downgraded the following day (when MCP lost a quarter of its value). Taking a breather from disappearing, shares +1.3% premarket.
Molycorp (MCP) has its price target lowered again by JPMorgan, this time to $8.50 as the firm...
From other sites
at CNBC.com (Jul 4, 2014)
at CNBC.com (Jun 16, 2014)
at CNBC.com (Jun 4, 2014)
at CNBC.com (Apr 25, 2014)
at CNBC.com (Mar 5, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs